Latest Master Validation Plan - The Unwritten Requirements

Overview: FDA Warning Letters and recent high-profile recalls indicate major cGMP deficiencies in many companies. One major failing is lack of sufficient or targeted risk-based company-wide V&V planning. Why should you Attend: Verification and validation requirements have always been part of the US FDA's GMPs.However, with increasing technology, bothindustry and regulatory agencies expectations have increased.